NCT00350961View on ClinicalTrials.gov

Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

February 29, 2008

Conditions
Cholangiocarcinoma
Interventions
DRUG

Gemcitabine

DRUG

Oxaliplatin

DRUG

Capecitabine

Trial Locations (2)

2100

Rigshospitalet, Copenhagen

7100

Vejle Sygehus, Vejle

All Listed Sponsors
collaborator

Henrik Jensen, Dept. of Oncology, Vejle Sygehus, Vejle, Denmark

UNKNOWN

lead

Rigshospitalet, Denmark

OTHER

NCT00350961 - Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma | Biotech Hunter | Biotech Hunter